Estimaciones de analistas de Wall Street para Aehr Test Systems (AEHR): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Consenso de analistas
| Compra fuerte | 0 |
| Compra | 1 |
| Mantener | 2 |
| Venta | 0 |
| Venta fuerte | 0 |
| Analistas totales | 3 |
| Calificación media (1-5) | 0.33 |
Sorpresas de Resultados Recientes
| Fecha | BPA Real | BPA Estimado | vs Est. |
|---|---|---|---|
| 2026-10-05 | $0.11 | ||
| 2026-07-14 | $0.11 | $-0.01 | +1200.0% |
| 2026-04-07 | $-0.05 | $-0.07 | +28.6% |
| 2026-01-08 | $-0.04 | $-0.08 | +50.0% |
| 2025-10-06 | $0.01 | $0.01 | +0.0% |
| 2025-07-08 | $-0.01 | $-0.01 | +33.3% |
| 2025-04-08 | $0.07 | $0.01 | +600.0% |
| 2025-01-13 | $0.02 | $0.03 | -33.3% |
Ratios de valoración
| Precio / Valor contable | 11.52 |
| EV / EBITDA | -217.68 |
| Rentabilidad por dividendo | 0.00% |
Cuenta de Resultados (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | $18.9M | $29.6M | $21.1M | $22.3M | $16.6M | $50.8M | $65.0M | $66.2M | $59.0M | $50.0M |
| Coste de Ventas | $12.1M | $17.2M | $13.5M | $13.9M | $10.6M | $27.2M | $32.2M | $33.7M | $35.0M | $32.4M |
| Beneficio Bruto | $6.8M | $12.4M | $7.6M | $8.4M | $6.0M | $23.7M | $32.7M | $32.5M | $23.9M | $17.7M |
| I+D | $4.7M | $4.2M | $4.2M | $3.4M | $3.7M | $5.8M | $7.1M | $8.7M | $10.5M | $12.6M |
| Generales y Administrativos | $7.1M | $7.3M | $7.7M | $7.5M | $6.6M | $10.0M | $12.2M | $13.7M | $17.8M | $19.2M |
| Gastos Operativos | $11.7M | $11.5M | $11.9M | $10.9M | $10.2M | $15.9M | $19.4M | $22.5M | $28.2M | $31.8M |
| Beneficio Operativo | -$4.9M | $915000 | -$4.3M | -$2.5M | -$4.2M | $7.8M | $13.4M | $10.1M | -$4.3M | -$14.1M |
| EBITDA | -$4.7M | $1.3M | -$4.5M | -$2.4M | -$1.8M | $9.8M | $15.1M | $13.8M | -$903000 | -$11.7M |
| Gastos por Intereses | $678000 | $399000 | $252000 | 0 | $46000 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Antes de Impuestos | -$5.6M | $455000 | -$5.2M | -$2.8M | -$2.2M | $9.5M | $14.6M | $12.5M | -$4.3M | -$11.7M |
| Impuestos | $25000 | -$73000 | $27000 | $36000 | -$177000 | $91000 | $60000 | -$20.7M | -$381000 | -$4.6M |
| Beneficio Neto | -$5.7M | $528000 | -$5.2M | -$2.8M | -$2.0M | $9.4M | $14.6M | $33.2M | -$3.9M | -$7.1M |
| BPA | $-0.35 | $0.02 | $-0.23 | $-0.12 | $-0.09 | $0.36 | $0.52 | $1.15 | $-0.13 | $-0.23 |
| BPA Diluido | $-0.35 | $0.02 | $-0.23 | $-0.12 | $-0.09 | $0.34 | $0.50 | $1.12 | $-0.13 | $-0.23 |
| Acciones en Circulación (Diluidas) | $16.3M | $22.8M | $22.4M | $22.9M | $23.5M | $27.8M | $29.2M | $29.6M | $29.6M | $30.7M |
Precio
| Precio | $84.25 |
| Capitalización | $2.7B |
| Bolsa | NASDAQ |
| País | US |
Empresas relacionadas: AOSL · CEVA · CTLP · ICHR · IMOS · ITRN · LAES
Explorar sector: Technology · Semiconductors
Más secciones de AEHR: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones